Stereotaxis, Inc.
STXS- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001289340
No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Stereotaxis, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 93 | 1 | 85 | −7 |
| Shares | 40.2M | 8.11K | 36.6M | −3.62M (−9.0%) |
| Value | $150.1M | $30.0K | $67.3M | −$82.8M (−55.1%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Stereotaxis, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Penn Capital Management Co Inc | 594,382 | $1.09M | 0.12% |
| Prescott Group Capital Management, L.L.C. | 317,460 | $584.0K | 0.16% |
| Jacobs Levy Equity Management, Inc | 245,198 | $451.0K | 0.00% |
| Ergoteles LLC | 243,900 | $449.0K | 0.01% |
| D. E. Shaw & Co., Inc. | 210,081 | $387.0K | 0.00% |
| North Run Capital, LP | 194,650 | $358.0K | 0.73% |
| Susquehanna International Group, LLP | 98,607 | $181.0K | 0.00% |
| Marshall Wace, LLP | 69,418 | $128.0K | 0.00% |
| State of Wyoming | 52,678 | $97.0K | 0.06% |
| Qube Research & Technologies Ltd | 46,791 | $86.0K | 0.00% |
| XTX Topco Ltd | 45,620 | $84.0K | 0.03% |
| Boothbay Fund Management, LLC | 19,583 | $36.0K | 0.00% |
| LMR Partners LLP | 17,703 | $33.0K | 0.00% |
| Balyasny Asset Management LLC | 12,523 | $23.0K | 0.00% |
| Jane Street Group, LLC | 11,609 | $21.0K | 0.00% |
| Credit Suisse AG | 26 | $0 | 0.00% |
Sold out (23)
Institutions that held Stereotaxis, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (1)
Institutions that held Stereotaxis, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 8,107 | $30.0K |